You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 5, 2025

Details for Patent: 8,962,829


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,962,829
Title:Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof
Abstract: The disclosure describes methods of synthesis of phosphonate ester compounds. The methods according to the disclosure allow for large-scale preparation of phosphonate ester compounds having high purity and stability. Also disclosed are morphic forms of phosphonate ester compounds.
Inventor(s): Ware, Jr.; Roy Wendell (Raleigh, NC), Downey; Aaron Leigh (Durham, NC)
Assignee: Chimerix, Inc. (Durham, NC)
Application Number:14/512,335
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Process;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,962,829

Introduction

Understanding the scope and claims of a patent is crucial for inventors, patent attorneys, and businesses to navigate the complex landscape of intellectual property. This article will delve into the specifics of United States Patent 8,962,829, exploring its claims, scope, and the broader patent landscape.

Patent Overview

United States Patent 8,962,829, hereafter referred to as the '829 patent, is a utility patent granted by the United States Patent and Trademark Office (USPTO). To analyze this patent, one must first identify its key components:

Patent Title and Abstract

The title and abstract provide a preliminary understanding of the invention. While the specific title and abstract of the '829 patent are not provided here, these sections typically outline the main subject matter and the problem the invention solves.

Claims

The claims section is the most critical part of a patent, as it defines the scope of the invention. Claims are the legal boundaries that distinguish the patented invention from prior art and other inventions.

Independent and Dependent Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. They are the broadest claims and set the foundation for the dependent claims.
  • Dependent Claims: These claims refer back to and further limit the independent claims. They often add specific details or features to the invention.

Claim Analysis

To analyze the claims of the '829 patent, one would typically use resources such as the USPTO's Patent Public Search tool or the Patent and Trademark Resource Centers (PTRCs)[1].

Description and Drawings

The description and drawings provide detailed explanations and visual representations of the invention. These sections help in understanding how the invention works and its various components.

Scope of the Invention

The scope of the '829 patent is defined by its claims. Here are some key points to consider:

Claim Scope Measurements

The USPTO's Patent Claims Research Dataset can provide insights into claim scope measurements. This dataset includes detailed information on claims from US patents and can help in understanding the breadth and depth of the claims in the '829 patent[3].

Prior Art and Citation Data

The Common Citation Document (CCD) application is useful for identifying prior art cited by multiple patent offices. This tool helps in understanding how the '829 patent differentiates itself from existing inventions[1].

Patent Landscape

Understanding the patent landscape involves looking at related patents, patent families, and the broader intellectual property environment.

Patent Family

Using the Global Dossier service, one can identify the patent family for the '829 patent, including all related applications filed at participating IP Offices. This helps in seeing how the invention fits into a larger series of related patents[1].

Office Actions and Prosecution History

The Global Dossier also provides access to the file histories of related applications, including office actions. This information is crucial for understanding the challenges and modifications made during the patent prosecution process[1].

Legal and Regulatory Considerations

Obviousness-Type Double Patenting (ODP)

The '829 patent, like other patents, must comply with rules against obviousness-type double patenting (ODP). This involves ensuring that the patent does not claim an invention that is obvious in view of another patent filed by the same inventor[4].

Patent Term Adjustment (PTA)

The patent term adjustment (PTA) is another critical aspect. PTA can extend the term of a patent due to delays in the USPTO's processing. However, this must be considered in conjunction with any terminal disclaimers and ODP analyses[4].

Practical Implications

Licensing and Litigation

Understanding the scope and claims of the '829 patent is essential for licensing agreements and litigation. It helps in determining whether a product or process infringes on the patented invention.

Innovation and R&D

For companies involved in research and development, analyzing the '829 patent can provide insights into existing technologies and guide the development of new innovations that do not infringe on existing patents.

Tools and Resources for Analysis

USPTO Resources

  • Patent Public Search: A powerful tool for searching prior art and analyzing patent claims[1].
  • Global Dossier: Provides access to file histories and related applications[1].
  • Common Citation Document (CCD): Consolidates citation data from multiple patent offices[1].

Patent and Trademark Resource Centers (PTRCs)

These centers offer local search resources and training in patent search techniques, which can be invaluable for detailed analysis[1].

Key Takeaways

  • Claims Analysis: The claims section is the heart of a patent and defines its scope.
  • Prior Art and Citation Data: Tools like the CCD help in understanding how the patent differentiates itself from prior art.
  • Patent Family and Prosecution History: Global Dossier provides insights into related applications and office actions.
  • Legal Considerations: ODP and PTA are critical legal aspects that must be considered.
  • Practical Implications: Understanding the patent is crucial for licensing, litigation, and R&D.

FAQs

Q: How do I search for existing patents related to my invention?

A: You can use the USPTO's Patent Public Search tool or visit a Patent and Trademark Resource Center (PTRC) for assistance[1].

Q: What is the importance of the claims section in a patent?

A: The claims section defines the legal boundaries of the invention and distinguishes it from prior art.

Q: How can I determine if my product infringes on an existing patent?

A: Analyze the claims of the existing patent and compare them with your product's features and functionalities.

Q: What is the Global Dossier service, and how is it useful?

A: The Global Dossier service provides access to the file histories of related applications from participating IP Offices, helping you understand the patent family and prosecution history[1].

Q: What is obviousness-type double patenting (ODP), and why is it important?

A: ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent filed at the same time but with a different patent term due to PTA[4].

Sources

  1. USPTO: Search for patents - USPTO. Retrieved from https://www.uspto.gov/patents/search
  2. USA.gov: U.S. Patent and Trademark Office (USPTO) | USAGov. Retrieved from https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. USPTO: Patent Claims Research Dataset - USPTO. Retrieved from https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. United States Court of Appeals for the Federal Circuit: In re Cellect - United States Court of Appeals for the Federal Circuit. Retrieved from https://cafc.uscourts.gov/opinions-orders/22-1293.OPINION.8-28-2023_2181381.pdf
  5. Administrative Conference of the United States: U.S. Patent Small Claims Court. Retrieved from https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 8,962,829

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Emergent Biodefense TEMBEXA brincidofovir TABLET;ORAL 214461-001 Jun 4, 2021 RX Yes Yes 8,962,829 ⤷  Try for Free Y Y ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 1 of 1 entries

International Family Members for US Patent 8,962,829

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2014349103 ⤷  Try for Free
Australia 2017202386 ⤷  Try for Free
Australia 2017203315 ⤷  Try for Free
Brazil 112016010862 ⤷  Try for Free
Canada 2929593 ⤷  Try for Free
China 105899215 ⤷  Try for Free
China 111777639 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 7 of 7 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.